AXA SA (CS.PA) Fundamental Analysis & Valuation

EPA:CS • FR0000120628

Current stock price

40.51 EUR
+0.34 (+0.85%)
Last:

This CS.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. CS.PA Profitability Analysis

1.1 Basic Checks

  • CS had positive earnings in the past year.
  • CS had a positive operating cash flow in the past year.
  • Of the past 5 years CS 4 years were profitable.
  • CS had a positive operating cash flow in 4 of the past 5 years.
CS.PA Yearly Net Income VS EBIT VS OCF VS FCFCS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

1.2 Ratios

  • The Return On Assets of CS (1.18%) is comparable to the rest of the industry.
  • CS has a better Return On Equity (16.72%) than 65.12% of its industry peers.
  • CS has a better Return On Invested Capital (1.28%) than 60.47% of its industry peers.
  • CS had an Average Return On Invested Capital over the past 3 years of 1.29%. This is in line with the industry average of 2.95%.
Industry RankSector Rank
ROA 1.18%
ROE 16.72%
ROIC 1.28%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
CS.PA Yearly ROA, ROE, ROICCS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • CS has a Profit Margin (8.52%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of CS has grown nicely.
  • CS has a Operating Margin of 11.47%. This is comparable to the rest of the industry: CS outperforms 46.51% of its industry peers.
  • CS's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.47%
PM (TTM) 8.52%
GM N/A
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
CS.PA Yearly Profit, Operating, Gross MarginsCS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CS.PA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CS is destroying value.
  • There is no outstanding debt for CS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CS.PA Yearly Shares OutstandingCS.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CS.PA Yearly Total Debt VS Total AssetsCS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B

2.2 Solvency

  • CS has an Altman-Z score of 0.35. This is a bad value and indicates that CS is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CS (0.35) is better than 88.37% of its industry peers.
  • CS has a debt to FCF ratio of 1.41. This is a very positive value and a sign of high solvency as it would only need 1.41 years to pay back of all of its debts.
  • The Debt to FCF ratio of CS (1.41) is better than 72.09% of its industry peers.
  • A Debt/Equity ratio of 0.65 indicates that CS is somewhat dependend on debt financing.
  • CS has a Debt to Equity ratio (0.65) which is comparable to the rest of the industry.
  • Although CS's pure debt/equity ratio does not look good, it has limited outstanding debt compared to the Free Cash Flow. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 1.41
Altman-Z 0.35
ROIC/WACC0.12
WACC10.72%
CS.PA Yearly LT Debt VS Equity VS FCFCS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.3 Liquidity

  • A Current Ratio of 0.82 indicates that CS may have some problems paying its short term obligations.
  • CS's Current ratio of 0.82 is amongst the best of the industry. CS outperforms 86.05% of its industry peers.
  • CS has a Quick Ratio of 0.82. This is a bad value and indicates that CS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 0.82, CS belongs to the best of the industry, outperforming 86.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
CS.PA Yearly Current Assets VS Current LiabilitesCS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CS.PA Growth Analysis

3.1 Past

  • CS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.52%.
  • Measured over the past years, CS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 17.68% on average per year.
EPS 1Y (TTM)7.52%
EPS 3Y7.81%
EPS 5Y17.68%
EPS Q2Q%6.4%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.13%

3.2 Future

  • Based on estimates for the next years, CS will show a small growth in Earnings Per Share. The EPS will grow by 6.68% on average per year.
  • Based on estimates for the next years, CS will show a quite strong growth in Revenue. The Revenue will grow by 8.16% on average per year.
EPS Next Y10.45%
EPS Next 2Y8.72%
EPS Next 3Y8.29%
EPS Next 5Y6.68%
Revenue Next Year0.15%
Revenue Next 2Y3.38%
Revenue Next 3Y2.31%
Revenue Next 5Y8.16%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
CS.PA Yearly Revenue VS EstimatesCS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50B 100B
CS.PA Yearly EPS VS EstimatesCS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

6

4. CS.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 10.49, which indicates a very decent valuation of CS.
  • Based on the Price/Earnings ratio, CS is valued a bit cheaper than the industry average as 74.42% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 25.60. CS is valued rather cheaply when compared to this.
  • Based on the Price/Forward Earnings ratio of 9.50, the valuation of CS can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CS indicates a somewhat cheap valuation: CS is cheaper than 79.07% of the companies listed in the same industry.
  • CS's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.84.
Industry RankSector Rank
PE 10.49
Fwd PE 9.5
CS.PA Price Earnings VS Forward Price EarningsCS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, CS is valued cheaper than 81.40% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.05
EV/EBITDA N/A
CS.PA Per share dataCS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • CS's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1
PEG (5Y)0.59
EPS Next 2Y8.72%
EPS Next 3Y8.29%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CS.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 6.12%, CS is a good candidate for dividend investing.
  • CS's Dividend Yield is a higher than the industry average which is at 4.47.
  • CS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 6.12%

5.2 History

  • On average, the dividend of CS grows each year by 8.12%, which is quite nice.
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
CS.PA Yearly Dividends per shareCS.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • 61.79% of the earnings are spent on dividend by CS. This is not a sustainable payout ratio.
  • The dividend of CS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP61.79%
EPS Next 2Y8.72%
EPS Next 3Y8.29%
CS.PA Yearly Income VS Free CF VS DividendCS.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B
CS.PA Dividend Payout.CS.PA Dividend Payout, showing the Payout Ratio.CS.PA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CS.PA Fundamentals: All Metrics, Ratios and Statistics

AXA SA

EPA:CS (4/2/2026, 7:00:00 PM)

40.51

+0.34 (+0.85%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-26
Earnings (Next)07-30
Inst Owners38.26%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap84.69B
Revenue(TTM)N/A
Net Income(TTM)7.61B
Analysts82.67
Price Target46.89 (15.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.12%
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP61.79%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.96%
PT rev (3m)2.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.29%
EPS NY rev (3m)-0.53%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.57%
Revenue NY rev (3m)-3.17%
Valuation
Industry RankSector Rank
PE 10.49
Fwd PE 9.5
P/S 0.95
P/FCF 4.05
P/OCF 3.96
P/B 1.86
P/tB 3.51
EV/EBITDA N/A
EPS(TTM)3.86
EY9.53%
EPS(NY)4.26
Fwd EY10.52%
FCF(TTM)10.01
FCFY24.71%
OCF(TTM)10.24
OCFY25.27%
SpS42.7
BVpS21.76
TBVpS11.53
PEG (NY)1
PEG (5Y)0.59
Graham Number43.47
Profitability
Industry RankSector Rank
ROA 1.18%
ROE 16.72%
ROCE 1.62%
ROIC 1.28%
ROICexc 1.33%
ROICexgc 1.74%
OM 11.47%
PM (TTM) 8.52%
GM N/A
FCFM 23.44%
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexgc growth 3Y10.47%
ROICexgc growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 1.41
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.53%
Interest Coverage 1.98
Cash Conversion N/A
Profit Quality 275.1%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 0.35
F-Score7
WACC10.72%
ROIC/WACC0.12
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)7.52%
EPS 3Y7.81%
EPS 5Y17.68%
EPS Q2Q%6.4%
EPS Next Y10.45%
EPS Next 2Y8.72%
EPS Next 3Y8.29%
EPS Next 5Y6.68%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%17.13%
Revenue Next Year0.15%
Revenue Next 2Y3.38%
Revenue Next 3Y2.31%
Revenue Next 5Y8.16%
EBIT growth 1Y7.05%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year26.98%
EBIT Next 3Y11.06%
EBIT Next 5Y9.48%
FCF growth 1Y150.74%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y145.39%
OCF growth 3Y7.85%
OCF growth 5Y9.48%

AXA SA / CS.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of AXA SA (CS.PA) stock?

ChartMill assigns a fundamental rating of 5 / 10 to CS.PA.


What is the valuation status of AXA SA (CS.PA) stock?

ChartMill assigns a valuation rating of 6 / 10 to AXA SA (CS.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for AXA SA?

AXA SA (CS.PA) has a profitability rating of 5 / 10.


What is the financial health of AXA SA (CS.PA) stock?

The financial health rating of AXA SA (CS.PA) is 5 / 10.


Can you provide the expected EPS growth for CS stock?

The Earnings per Share (EPS) of AXA SA (CS.PA) is expected to grow by 10.45% in the next year.